Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07224295 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of Non Invasive Stellate Ganglion Disrupting on Sleep Disturbances on Postmenopausal Female

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Completed without a posted recruiting period Show 5 more changesShow less
    • Primary completion date changed from estimate of Mar 1, 2026 to May 1, 2026
    • Study completion date changed from estimate of Mar 1, 2026 to Jul 1, 2026
    • Eligibility criteria expanded, about 11 words
    • Site contact updated
    • Study description expanded, about 2 words
  2. Primary and study completion dates: Feb 10, 2026 to Mar 1, 2026
    • Start date: Nov 10, 2025 to Dec 1, 2025
    v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to asses the effect of non invasive stellate ganglion disrupting on sleep distyrbances on postmenopausal female . The primary hypothesis: There is no effect of noninvasive stellate ganglion disrupting on sleep disturbance parameters of postmenopausal women. There is no effect of noninvasive stellate ganglion disrupting on quality of female's life Non invasive stellate ganglion disrupting with physical modality TENS will be applied on participants of study group. The participants will be screened for estradiol level and assed for the quality of sleep by specialized questionnaire.
Trial Details
NCT Number NCT07224295
Lead Sponsor Kafrelsheikh University
Conditions
(from sponsor)		 Sleep Disturbances
Related terms Parasomnias
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov